Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Advanced Sarcoma
NCT01830153Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Apr 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in soft tissue sarcoma (STS), bone sarcoma, sponsored by Asan Medical Center. Started Apr 2010; status: completed.
02
Drugs
everolimus
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT01830153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830153.